Security key
207523101
Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB)
CUSIP: 207523101
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Ordinary shares, par value $0.000174
- Shares outstanding
- 62,516,710
- Total 13F shares
- 1,582
- Share change
- -2,443,238
- Total reported value
- $2,389
- Price per share
- $1.51
- Number of holders
- 1
- Value change
- -$2,397,515
- Number of sells
- 16
Report period
Q3 2025
Institutions
1
Top holders
1
CNTB full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Connect Biopharma Holdings Ltd SEC filings
Connect Biopharma Holdings Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP 207523101
Recent filing periods:
Top shareholders of CNTB - Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Panacea Innovation Ltd |
13D/G
|
Panacea Innovation Limited |
25%
|
13,950,000
|
$13,950,000 | $0 | 21 Jul 2025 | |
| BML Capital Management, LLC |
13F
|
Company |
2.9%
|
1,821,558
|
$1,785,127 | — | 30 Jun 2025 | |
| CHOREO, LLC |
13F
|
Company |
0.26%
|
160,867
|
$157,650 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.23%
|
143,700
|
$140,826 | — | 30 Jun 2025 | |
| AlphaCore Capital LLC |
13F
|
Company |
0.13%
|
80,000
|
$78,400 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.1%
|
61,992
|
$61,992 | — | 30 Jun 2025 | |
| Koa Wealth Management, LLC |
13F
|
Company |
0.08%
|
49,600
|
$48,608 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.06%
|
40,400
|
$40,000 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.05%
|
28,862
|
$28,862 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
23,320
|
$23,320 | — | 30 Jun 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
20,000
|
$20,000 | — | 30 Jun 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.02%
|
10,300
|
$10,094 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
2,370
|
$2,370 | — | 30 Jun 2025 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
1,582
|
$1,550 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
121
|
$121 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
100
|
$98 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
42
|
$41 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
6
|
$6 | — | 30 Jun 2025 |
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB) as of Q3 2025
As of 30 Sep 2025,
Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
1,582 shares.
The largest 1 holders included
EverSource Wealth Advisors, LLC.
This page lists
1
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
17
Q3 2025 holders
1
Holder diff
-16
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.